| Evaluation of the Efficacy of Almotriptan and Ubrogepant for the Acute Treatment of Migraine (NCT05214001) | Messoud Ashina, MD | 2022-06-30 |
| Evaluation of the Efficacy of Diclofenac Potassium and Rimegepant for the Acute Treatment of Migraine (NCT05211154) | Danish Headache Center | 2022-05-05 |
| Transnasal Cooling for Migraine (NCT04936061) | CoolTech LLC | 2021-10-14 |
| Efficacy of CLORazepate for the Treatment of MIGraine Attack in the Emergency Room (NCT04726592) | Assistance Publique - Hôpitaux de Paris | 2021-07-08 |
| Digital Treatment for Migraines - a Feasibility Study (NCT05018572) | Vastra Gotaland Region | 2021-07-01 |
| A Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Assess STS101 in the Acute Treatment of Migraine (NCT04940390) | Satsuma Pharmaceuticals, Inc. | 2021-06-30 |
| Mind Body Balance for Pediatric Migraine (NCT04715685) | Children's Hospital Medical Center, Cincinnati | 2021-03-09 |
| A Study of the PK and Safety of Single Doses of STS101, DHE Injection and Nasal Spray in Healthy Subjects (NCT05337254) | Satsuma Pharmaceuticals, Inc. | 2021-03-05 |
| The Effect of Anti-calcitonin Gene-related Peptide (CGRP) Receptor Antibodies on the Headache Inducing Properties of CGRP and Cilostazol in Migraine Patients (NCT04452929) | Danish Headache Center | 2020-07-22 |
| A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate STS101 in the Acute Treatment of Migraine (NCT03901482) | Satsuma Pharmaceuticals, Inc. | 2019-06-24 |
| A Phase I Study to Study the PK and Safety of Single Doses of STS101, DHE Injection and Nasal Spray in Healthy Subjects (NCT03874832) | Satsuma Pharmaceuticals, Inc. | 2018-09-11 |
| Can DFN-15 Terminate Migraine With Allodynia? (NCT03472378) | Hartford Hospital | 2018-05-09 |
| Sensitivity to Acute Cerebral Ischemia in Migrainers (NCT03301441) | University Hospital, Montpellier | 2018-02-09 |
| Evaluation of a Novel Device for Treatment of Migraine Headache (NCT03361423) | Theranica | 2017-12-17 |
| Integrative Migraine Pain Alleviation Through Chiropractic Therapy (NCT03177616) | Harvard University Faculty of Medicine | 2017-06-07 |
| Continue or Stop Applying Wet Cupping (Al-Hijamah) in Migraine (NCT03479060) | Karabuk University | 2017-01-03 |
| Partial Rebreathing in the Treatment of Migraine With Aura (NCT03472417) | University of Aarhus | 2016-11-01 |
| Endothelin-1 as a Potential Trigger of Migraine Aura (NCT02906085) | Glostrup University Hospital, Copenhagen | 2016-10-01 |
| Pharmacologically Triggered Migraine Without Aura and Neuroimaging (NCT03143465) | Danish Headache Center | 2016-08-01 |
| Brainstem Grey Matter and Cerebral Autoregulation in Migraine With Aura. (NCT02708797) | University Hospital, Toulouse | 2016-05-01 |
| Mindfulness for Adolescents for CM and HFEM (NCT04968093) | Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta | 2016-01-01 |
| Induction of Migraine Aura With Sildenafil (NCT02795351) | Herlev Hospital | 2015-06-01 |
| Induction of Migraine Aura With Cilostazol (NCT02253004) | Herlev Hospital | 2014-09-01 |
| IndoProCaf Effervescent Tablets Effectiveness in Acute Treatment of Migraine and/or Episodic Tension-type Headache and Patients' Satisfaction With the Treatment in Routine Clinical Practice (NCT02115269) | Abbott | 2014-06-01 |
| Impact of a Nurse for Migraine Management: the IMPACT Project (NCT01804517) | Notre-Dame Hospital, Montreal, Quebec, Canada | 2013-02-01 |
| Is Chiropractic Spinal Manipulative Therapy an Efficient Treatment Option for Migraine (NCT01741714) | University Hospital, Akershus | 2013-02-01 |
| Efficacy and Safety of Oral Sumatriptan Plus Oral Promethazine in Migraine Treatment (NCT01814189) | Shahid Beheshti University of Medical Sciences | 2013-01-01 |
| Investigation of the Blood-brain and Blood-dura Barrier Durin Migraine Attacks Using MRI (NCT02202486) | Glostrup University Hospital, Copenhagen | 2012-09-01 |
| The Impact of Triptan and Doxycycline on Neuroinflammatory Biomarkers in Acute Migraine (NCT01653522) | The Cleveland Clinic | 2012-07-01 |
| Impact of tDCS on Cerebral Autoregulation (NCT01865604) | Charite University, Berlin, Germany | 2012-04-01 |
| Intravenous Ketorolac and Metoclopramide for Pediatric Migraine in the Emergency Department (NCT01596166) | University of Alberta | 2012-02-01 |
| Preventive Treatment of Episodic and Chronic Migraine (NCT01319825) | California Medical Clinic for Headache | 2011-04-01 |
| Women With Migraine With Aura Neuroimaging Study (NCT02047695) | Odense University Hospital | 2011-02-01 |
| Functional MRI and MRA in Migraine With Aura (NCT01388894) | Glostrup University Hospital, Copenhagen | 2010-12-01 |
| Efficacy of Sumatriptan With Naprosyn in Migraine With Aura (NCT00893594) | Dent Neurologic Institute | 2010-10-01 |
| Migraine and Endothelial Dysfunction (NCT01388699) | Charite University, Berlin, Germany | 2010-10-01 |
| Oxygenation and Perfusion in Patients With Acute Migraine Attacks (NCT03536936) | Insel Gruppe AG, University Hospital Bern | 2010-01-01 |
| Comorbidities Associated With Migraine and Patent Foramen Ovale (CAMP) (NCT01257880) | Swedish Medical Center | 2010-01-01 |
| Study of NXN 188 for the Treatment of Migraine With Aura (NCT00920686) | NeurAxon Inc. | 2009-06-01 |
| Study of the Safety and Effectiveness of NXN-188 for the Acute Treatment of Migraine Attacks With Aura (NCT00877838) | Danish Headache Center | 2009-05-01 |
| Candesartan Versus Propranolol for Migraine Prevention (NCT00884663) | Norwegian University of Science and Technology | 2009-04-01 |
| Calcitonin Gene-related Peptide in Familial Hemiplegic Migraine (FHM) and Migraine With Aura (MA) (NCT00687947) | Danish Headache Center | 2008-05-01 |
| A Study of a Melatonin Receptor Agonist to Prevent Migraine (NCT00739024) | Swedish Medical Center | 2008-04-01 |
| Dose Ranging Study of the Efficacy and Tolerability of Tonabersat in the Prophylaxis of Migraine Headache (NCT00534560) | Minster Research Ltd | 2007-10-01 |
| Efficacy and Safety Clinical Trial of Intranasal AST-726 for the Prevention of Migraine (NCT00285402) | Ariston Pharmaceuticals, Inc. | 2007-05-01 |
| Maxalt 10mg Plus Caffeine 75mg in the Acute Treatment of Migraine Headache (NCT00471952) | Diamond Headache Clinic | 2007-04-01 |
| Efficacy and Safety of TMS for the Preemptive Treatment of Migraine With Aura (NCT00449540) | Neuralieve | 2006-08-01 |
| PRIMA PFO Migraine Trial (NCT00505570) | Abbott Medical Devices | 2006-05-01 |
| Tonabersat in the Prophylaxis of Migraine With Aura (NCT00332007) | Minster Research Ltd | 2006-05-01 |
| Efficacy and Tolerability of Tonabersat in the Prophylaxis of Migraine Headache (NCT00311662) | Minster Research Ltd | 2006-04-01 |
| Study to Evaluate the Efficacy and Safety of Dronabinol Metered Dose Inhaler (MDI) in Acute Treatment of Migraine Headache (NCT00123201) | Solvay Pharmaceuticals | 2005-09-01 |
| Evaluation of the Efficacy and Safety of Laxymig® as Prophylactic Treatment in Patients With Migraine (NCT00334178) | Lotus Pharmaceutical | 2004-11-01 |
| Eletriptan Provides Consistent Migraine Relief: Results Of A Within-Patient Multiple-Dose Study (NCT01859481) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2000-03-01 |